Log in
Enquire now
‌

US Patent 9517295 Blood treatment systems and methods

Patent 9517295 was granted and assigned to DEKA (company) on December, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Patent abstractTimelineTable: Further ResourcesReferences
Is a
Patent
Patent

Patent attributes

Current Assignee
DEKA (company)
DEKA (company)
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9517295
Date of Patent
December 13, 2016
Patent Application Number
13480454
Date Filed
May 24, 2012
Patent Citations Received
‌
US Patent 12078162 Liquid pumping cassettes and associated pressure distribution manifold and related methods
3
‌
US Patent 12059516 Blood circuit assembly for a hemodialysis system
4
‌
US Patent 12064540 Hemodialysis systems and methods
5
‌
US Patent 12066017 Pumping cassette
6
‌
US Patent 11666690 Blood treatment systems and methods
7
‌
US Patent 11696977 Medical fluid delivery system including remote machine updating and control
8
‌
US Patent 11754064 Fluid pumping systems, devices and methods
‌
US Patent 11752244 Blood circuit assembly for a hemodialysis system
...
Patent Primary Examiner
‌
John Kim
Patent abstract

Dialysis systems are disclosed comprising new fluid flow circuits. Systems may include blood and dialysate flow paths, where the dialysate flow path includes balancing, mixing, and/or directing circuits. Dialysis systems may include a safety system utilizing a field programmable gate array (FPGA) that monitors at least conductivity and temperature of dialysate in the flow circuit upstream of a dialyzer and enters a fail-safe state if the measured conductivity is outside of a range of values. The FPGA may be verified to be operating properly by exposing sensors in fluid paths to temperatures or conductivities that are outside pre-determined permissible ranges of values, and confirming that the FPGA safety system enters a fail-safe state in response to the temperatures or conductivities. The FPGA may be configured to monitor an amount of ultrafiltration fluid withdrawn from a patient during dialysis treatment and to enter a fail-safe state if a maximum amount is exceeded.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9517295 Blood treatment systems and methods

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.